TLRY Tilray

Elevate Everyday Wellness Rituals With Solei Cannabis Teas

Elevate Everyday Wellness Rituals With Solei Cannabis Teas

Solei Introduces Three New Seasonal Brews for Tea Lovers

TORONTO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announces the latest seasonal release from its cannabis wellness brand, . Joining its list of elevation essentials, Solei introduces three new cannabis-infused tea blends, including Decaffeinated Jasmine Green Tea, Spiced Starlight, and Chai Rooibos that are now available, just in time for the cozy season ahead.

Earlier this Spring, Solei introduced its inaugural tea collection with the launch of , focused on intentional consumption around its cannabinoid variations of CBD, CBN, and THC. Now back with three additional flavours, Solei delivers refreshing seasonal blends in premium sachets of loose-leaf tea.

Solei’s new seasonal brews include:

  • Decaffeinated Jasmine Green Tea: A premium whole-leaf tea with the classic aromas of jasmine flower. It contains five biodegradable pyramid tea sachets; each sachet includes 20mg of CBD and <1mg of THC perfect for any time of the day.
  • Spiced Starlight: With 5x5g premium whole-leaf tea bags, this rich, Spiced Starlight multi-pack is caffeine-free and features warm spices of cardamom and clove. Each pack contains five biodegradable pyramid tea bag sachets, each infused with 20mg CBD, 10mg CBN, and <1mg THC. 
  • Chai Rooibos: Solei’s chai rooibos tea is a classic spice-filled beverage that’s caffeine-free, providing a sense of ease and comfort in a cup with notes of cardamom, cinnamon, and clove flavors. Each tea pack includes five biodegradable pyramid tea bag sachets, each infused with 20mg CBD and 2mg THC. 

Solei cannabis-infused teas are made for self-care routines, moments to unwind and to share socially with friends. Solei’s new teas – Jasmine Green Tea, Spiced Starlight, and Chai Rooibos, are now available at select Canadian cannabis retailers. For more information on where to buy Solei teas, please visit .

About Solei

Solei is a leading cannabis wellness and lifestyle brand with thoughtfully designed products for curating sensorial experiences based on what you need, when you need it, entirely on your terms. Beloved by consumers for its carefully formulated products and innovative formats, Solei products feature varied and rare cannabinoids that allow you to fine-tune your routines with ease. Explore a true sense of well-being with a wide range of formats including Solei’s best-selling CBD oils, ready-to-go pre-roll multi-packs, blended topicals, and new beverages, along with more exciting future launches coming later this year.

For more information on Solei, visit  and follow along our journey  on Instagram.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information on Tilray, visit . and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

Contacts:

Media:

Kaitlin Macapagal

Investors

Raphael Gross

203-682-8253



EN
13/12/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Medical erweitert Präsenz in Deutschland durch Einführung neuer...

Tilray Medical erweitert Präsenz in Deutschland durch Einführung neuer medizinischer Cannabissorten von Good Supply Tilray bekräftigt sein anhaltendes Engagement für das deutsche Gesundheitswesen und den Ausbau des Zugangs für Patienten und Apotheken auf Europas größtem Markt für medizinisches Cannabis LONDON und NEUMÜNSTER, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führendes Unternehmen im Bereich des medizinischen Cannabis, das die therapeutische Allianz zwischen Patienten und...

 PRESS RELEASE

Tilray Medical renforce sa présence en Allemagne en introduisant de no...

Tilray Medical renforce sa présence en Allemagne en introduisant de nouvelles variétés de cannabis thérapeutique Good Supply Tilray confirme son engagement constant envers le système de santé allemand et élargit l’accès des patients et des pharmacies au plus grand marché européen du cannabis thérapeutique LONDRES et NEUMÜNSTER, 28 août 2025 (GLOBE NEWSWIRE) -- Tilray Medical (« Tilray »), une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de santé de prendre ensemble des décisions...

 PRESS RELEASE

Tilray Medical Expands Presence in Germany with Introduction of New Go...

Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market LONDON and NEUMÜNSTER, Germany, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming h...

 PRESS RELEASE

Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bi...

Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that it received written notice from the Nasdaq Stock Market, LLC (“Nasdaq”) confirming that Tilray is again in compliance with Nasdaq’s minimum bid price requirement set forth in 5450(a)(1) of the Nasdaq Listing Rules. To achieve this,...

 PRESS RELEASE

Unleashing the Spirit of Adventure: Breckenridge Distillery Launches M...

Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir Mountain Shot Delivers an Elevated Whiskey Experience, Blending Smooth Chocolate Notes with a Refreshing Hint of Mint BRECKENRIDGE, Colo., Aug. 21, 2025 (GLOBE NEWSWIRE) -- , an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to announce its latest innovation, , a crafted experience infused with the natural complexity of mushrooms and distilled into a moment of pure delight. Mountain Shot is a unique beve...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch